Blood stream-breaking dispersing tablets
A blood-cutting and dispersible tablet technology, which is applied in the field of blood-breaking dispersible tablets, can solve problems such as difficult industrialization, adhesion, and high proportion content, and achieve the effect of large room for maneuver and improved disintegration
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0053] The weight percentage of traditional Chinese medicine extract and auxiliary materials of Duanxueliu dispersible tablet: fine powder of Duanxueliu extract 20%, crospovidone 24%, sodium carboxymethyl starch 20%, microcrystalline cellulose 10%, lactose 20%, Polyvinylpyrrolidone 3%, Magnesium Stearate 3%.
[0054] Duanxueliu dispersible tablets are obtained according to the following specific steps: take Duanxueliu, cut into sections, decoct twice with water for 1.5 hours each time, combine the decoctions, filter, and concentrate the filtrate to a relative density of 1.15 (80°C), Add 1.7 times the amount of ethanol, stir well, let it stand for 24 hours, take the supernatant and concentrate it under reduced pressure to form a thick paste, dry it into a dry extract, and pulverize it to obtain a fine powder of the blood flow extract.
[0055] First pass the above-mentioned materials through a 100-mesh sieve, and mix the fine powder of the broken blood flow extract with the mix...
Embodiment 2
[0057] 30% by weight of fine powder of broken blood extract, 20% sodium carboxymethylcellulose, 12% microcrystalline cellulose, 16% cross-linked polyvinylpyrrolidone, 5% polyvinylpyrrolidone, 10% lactose, polyethylene Pyrrolidone 4%, micronized silica gel 1%, magnesium lauryl sulfate 2%. All the other are with embodiment 1.
Embodiment 3
[0059] 36% by weight of fine powder of broken blood extract, 20% sodium carboxymethyl starch, 15% croscarmellose sodium, 6% crospovidone, 3% low-substituted hydroxypropyl cellulose , mannitol 9%, polyvinylpyrrolidone 7%, calcium stearate 2%, magnesium stearate 1%, HLB=15-16 sucrose fatty acid ester 1%. Sucrose fatty acid ester is P-1570 or P-1670 or LWA-1570, all the other are the same as embodiment 1.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com